Agenus Inc. is a biotechnology company focused on developing immune-oncology therapies, and recent news highlights their progress in advancing clinical trials for their cancer treatment candidates, including AGEN1181 and balstilimab. The company is also exploring partnerships and collaborations to enhance their drug development pipeline.